DGX Annual Cash & Cash Equivalents
$686.00 M
+$371.00 M+117.78%
31 December 2023
Summary:
As of January 22, 2025, DGX annual cash & cash equivalents is $686.00 million, with the most recent change of +$371.00 million (+117.78%) on December 31, 2023. During the last 3 years, it has fallen by -$472.00 million (-40.76%). DGX annual cash & cash equivalents is now -42.45% below its all-time high of $1.19 billion, reached on December 31, 2019.DGX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Quarterly Cash And Cash Equivalents
$764.00 M
+$493.00 M+181.92%
30 September 2024
Summary:
As of January 22, 2025, DGX quarterly cash and cash equivalents is $764.00 million, with the most recent change of +$493.00 million (+181.92%) on September 30, 2024. Over the past year, it has increased by +$78.00 million (+11.37%). DGX quarterly cash and cash equivalents is now -52.40% below its all-time high of $1.60 billion, reached on September 30, 2020.DGX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +117.8% | +11.4% |
| 3 y3 years | -40.8% | +11.4% |
| 5 y5 years | +408.1% | +11.4% |
DGX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.3% | +117.8% | -12.4% | +506.4% |
| 5 y | 5-year | -42.5% | +117.8% | -52.4% | +506.4% |
| alltime | all time | -42.5% | +2414.3% | -52.4% | +2700.2% |
Quest Diagnostics Incorporated Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $764.00 M(+181.9%) |
| June 2024 | - | $271.00 M(-42.8%) |
| Mar 2024 | - | $474.00 M(-30.9%) |
| Dec 2023 | $686.00 M(+117.8%) | $686.00 M(+379.7%) |
| Sept 2023 | - | $143.00 M(+13.5%) |
| June 2023 | - | $126.00 M(-28.0%) |
| Mar 2023 | - | $175.00 M(-44.4%) |
| Dec 2022 | $315.00 M(-63.9%) | $315.00 M(-55.0%) |
| Sept 2022 | - | $700.00 M(-11.4%) |
| June 2022 | - | $790.00 M(+11.0%) |
| Mar 2022 | - | $712.00 M(-18.3%) |
| Dec 2021 | $872.00 M(-24.7%) | $872.00 M(-11.7%) |
| Sept 2021 | - | $987.00 M(+76.3%) |
| June 2021 | - | $560.00 M(-54.5%) |
| Mar 2021 | - | $1.23 B(+6.2%) |
| Dec 2020 | $1.16 B(-2.9%) | $1.16 B(-27.9%) |
| Sept 2020 | - | $1.60 B(+62.4%) |
| June 2020 | - | $988.00 M(+188.9%) |
| Mar 2020 | - | $342.00 M(-71.3%) |
| Dec 2019 | $1.19 B(+783.0%) | $1.19 B(+174.7%) |
| Sept 2019 | - | $434.00 M(+59.0%) |
| June 2019 | - | $273.00 M(-41.2%) |
| Mar 2019 | - | $464.00 M(+243.7%) |
| Dec 2018 | $135.00 M(-1.5%) | $135.00 M(-48.7%) |
| Sept 2018 | - | $263.00 M(+99.2%) |
| June 2018 | - | $132.00 M(+6.5%) |
| Mar 2018 | - | $124.00 M(-9.5%) |
| Dec 2017 | $137.00 M(-61.8%) | $137.00 M(-60.9%) |
| Sept 2017 | - | $350.00 M(+11.5%) |
| June 2017 | - | $314.00 M(-14.4%) |
| Mar 2017 | - | $367.00 M(+2.2%) |
| Dec 2016 | $359.00 M(+169.9%) | $359.00 M(-11.6%) |
| Sept 2016 | - | $406.00 M(+43.5%) |
| June 2016 | - | $283.00 M(+121.1%) |
| Mar 2016 | - | $128.00 M(-3.8%) |
| Dec 2015 | $133.00 M(-30.7%) | $133.00 M(+8.1%) |
| Sept 2015 | - | $123.00 M(-18.0%) |
| June 2015 | - | $150.00 M(-84.6%) |
| Mar 2015 | - | $974.00 M(+407.3%) |
| Dec 2014 | $192.00 M(+2.7%) | $192.00 M(+12.9%) |
| Sept 2014 | - | $170.00 M(+18.1%) |
| June 2014 | - | $144.00 M(0.0%) |
| Mar 2014 | - | $144.00 M(-23.0%) |
| Dec 2013 | $187.00 M(-36.8%) | $187.00 M(+18.1%) |
| Sept 2013 | - | $158.28 M(+6.7%) |
| June 2013 | - | $148.34 M(+11.0%) |
| Mar 2013 | - | $133.60 M(-54.9%) |
| Dec 2012 | $296.00 M(+79.5%) | $296.00 M(+54.4%) |
| Sept 2012 | - | $191.77 M(+10.4%) |
| June 2012 | - | $173.74 M(+19.5%) |
| Mar 2012 | - | $145.44 M(-11.8%) |
| Dec 2011 | $164.89 M(-63.3%) | $164.89 M(+48.8%) |
| Sept 2011 | - | $110.83 M(-39.8%) |
| June 2011 | - | $184.22 M(-81.5%) |
| Mar 2011 | - | $994.24 M(+121.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $449.30 M(-15.9%) | $449.30 M(+0.3%) |
| June 2010 | - | $447.89 M(-3.3%) |
| Mar 2010 | - | $463.24 M(-13.3%) |
| Dec 2009 | $534.26 M(+110.4%) | $534.26 M(+116.3%) |
| Sept 2009 | - | $247.03 M(+107.1%) |
| June 2009 | - | $119.29 M(-41.6%) |
| Mar 2009 | - | $204.22 M(-19.6%) |
| Dec 2008 | $253.95 M(+51.5%) | $253.95 M(-11.4%) |
| Sept 2008 | - | $286.68 M(+99.9%) |
| June 2008 | - | $143.40 M(-15.7%) |
| Mar 2008 | - | $170.02 M(+1.4%) |
| Dec 2007 | $167.59 M(+12.0%) | $167.59 M(+1.8%) |
| Sept 2007 | - | $164.62 M(+34.6%) |
| June 2007 | - | $122.30 M(-22.8%) |
| Mar 2007 | - | $158.40 M(+5.9%) |
| Dec 2006 | $149.64 M(+62.4%) | $149.64 M(+42.4%) |
| Sept 2006 | - | $105.11 M(-30.2%) |
| June 2006 | - | $150.68 M(-3.7%) |
| Mar 2006 | - | $156.46 M(+69.8%) |
| Dec 2005 | $92.13 M(+25.7%) | $92.13 M(-56.1%) |
| Sept 2005 | - | $210.09 M(+2.9%) |
| June 2005 | - | $204.11 M(+136.9%) |
| Mar 2005 | - | $86.16 M(+17.5%) |
| Dec 2004 | $73.30 M(-52.7%) | $73.30 M(-63.5%) |
| Sept 2004 | - | $201.04 M(+45.9%) |
| June 2004 | - | $137.80 M(-27.5%) |
| Mar 2004 | - | $190.07 M(+22.7%) |
| Dec 2003 | $154.96 M(+60.1%) | $154.96 M(+70.2%) |
| Sept 2003 | - | $91.07 M(+3.4%) |
| June 2003 | - | $88.07 M(+58.4%) |
| Mar 2003 | - | $55.60 M(-42.6%) |
| Dec 2002 | $96.78 M(-20.9%) | $96.78 M(-15.0%) |
| Sept 2002 | - | $113.85 M(+26.7%) |
| June 2002 | - | $89.84 M(-39.9%) |
| Mar 2002 | - | $149.43 M(+22.1%) |
| Dec 2001 | $122.33 M(-28.7%) | $122.33 M(-48.8%) |
| Sept 2001 | - | $238.88 M(+37.2%) |
| June 2001 | - | $174.16 M(+44.3%) |
| Mar 2001 | - | $120.73 M(-29.6%) |
| Dec 2000 | $171.48 M(+528.5%) | $171.48 M(+6.0%) |
| Sept 2000 | - | $161.79 M(+62.7%) |
| June 2000 | - | $99.43 M(+249.0%) |
| Mar 2000 | - | $28.49 M(+4.4%) |
| Dec 1999 | $27.28 M(-86.6%) | $27.28 M(-25.9%) |
| Sept 1999 | - | $36.80 M(-75.2%) |
| June 1999 | - | $148.50 M(-3.7%) |
| Mar 1999 | - | $154.20 M(-24.0%) |
| Dec 1998 | $202.90 M(+25.5%) | $202.90 M(+12.1%) |
| Sept 1998 | - | $181.00 M(+18.5%) |
| June 1998 | - | $152.70 M(-11.5%) |
| Mar 1998 | - | $172.60 M(+6.7%) |
| Dec 1997 | $161.70 M(+285.4%) | $161.70 M(+29.9%) |
| Sept 1997 | - | $124.50 M(+64.2%) |
| June 1997 | - | $75.80 M(+11.6%) |
| Mar 1997 | - | $67.90 M |
| Dec 1996 | $41.96 M | - |
FAQ
- What is Quest Diagnostics Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated annual cash & cash equivalents year-on-year change?
- What is Quest Diagnostics Incorporated quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly cash and cash equivalents year-on-year change?
What is Quest Diagnostics Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of DGX is $686.00 M
What is the all time high annual cash & cash equivalents for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual cash & cash equivalents is $1.19 B
What is Quest Diagnostics Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, DGX annual cash & cash equivalents has changed by +$371.00 M (+117.78%)
What is Quest Diagnostics Incorporated quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DGX is $764.00 M
What is the all time high quarterly cash and cash equivalents for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly cash and cash equivalents is $1.60 B
What is Quest Diagnostics Incorporated quarterly cash and cash equivalents year-on-year change?
Over the past year, DGX quarterly cash and cash equivalents has changed by +$78.00 M (+11.37%)